United States Doxorubicin Market Report 2016

November 2016 | 97 pages | ID: UA1DD7C4709EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Doxorubicin

Revenue, means the sales value of Doxorubicin

This report studies sales (consumption) of Doxorubicin in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• Johnson & Johnson
• Sun Pharmaceutical Industries
• Meiji Seika Pharma
• MicroBiopharm Japan
• Teva
• Boryung
• Synbias Pharma
• Sterling
• LINGNAN Pharmaceutical

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Doxorubicin in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Doxorubicin Market Report 2016

1 DOXORUBICIN OVERVIEW

1.1 Product Overview and Scope of Doxorubicin
1.2 Classification of Doxorubicin
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Doxorubicin
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Doxorubicin (2011-2021)
  1.4.1 United States Doxorubicin Sales and Growth Rate (2011-2021)
  1.4.2 United States Doxorubicin Revenue and Growth Rate (2011-2021)

2 UNITED STATES DOXORUBICIN COMPETITION BY MANUFACTURERS

2.1 United States Doxorubicin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Doxorubicin Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Doxorubicin Average Price by Manufactures (2015 and 2016)
2.4 Doxorubicin Market Competitive Situation and Trends
  2.4.1 Doxorubicin Market Concentration Rate
  2.4.2 Doxorubicin Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES DOXORUBICIN SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Doxorubicin Sales and Market Share by Type (2011-2016)
3.2 United States Doxorubicin Revenue and Market Share by Type (2011-2016)
3.3 United States Doxorubicin Price by Type (2011-2016)
3.4 United States Doxorubicin Sales Growth Rate by Type (2011-2016)

4 UNITED STATES DOXORUBICIN SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Doxorubicin Sales and Market Share by Application (2011-2016)
4.2 United States Doxorubicin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES DOXORUBICIN MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Doxorubicin Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Johnson & Johnson
  5.2.2 Doxorubicin Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Johnson & Johnson Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Sun Pharmaceutical Industries
  5.3.2 Doxorubicin Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Sun Pharmaceutical Industries Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Meiji Seika Pharma
  5.4.2 Doxorubicin Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Meiji Seika Pharma Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 MicroBiopharm Japan
  5.5.2 Doxorubicin Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 MicroBiopharm Japan Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Teva
  5.6.2 Doxorubicin Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Teva Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Boryung
  5.7.2 Doxorubicin Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Boryung Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Synbias Pharma
  5.8.2 Doxorubicin Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Synbias Pharma Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Sterling
  5.9.2 Doxorubicin Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Sterling Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 LINGNAN Pharmaceutical
  5.10.2 Doxorubicin Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 LINGNAN Pharmaceutical Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview

6 DOXORUBICIN MANUFACTURING COST ANALYSIS

6.1 Doxorubicin Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Doxorubicin

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Doxorubicin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Doxorubicin Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES DOXORUBICIN MARKET FORECAST (2016-2021)

10.1 United States Doxorubicin Sales, Revenue Forecast (2016-2021)
10.2 United States Doxorubicin Sales Forecast by Type (2016-2021)
10.3 United States Doxorubicin Sales Forecast by Application (2016-2021)
10.4 Doxorubicin Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Doxorubicin
Table Classification of Doxorubicin
Figure United States Sales Market Share of Doxorubicin by Type in 2015
Table Application of Doxorubicin
Figure United States Sales Market Share of Doxorubicin by Application in 2015
Figure United States Doxorubicin Sales and Growth Rate (2011-2021)
Figure United States Doxorubicin Revenue and Growth Rate (2011-2021)
Table United States Doxorubicin Sales of Key Manufacturers (2015 and 2016)
Table United States Doxorubicin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Doxorubicin Sales Share by Manufacturers
Figure 2016 Doxorubicin Sales Share by Manufacturers
Table United States Doxorubicin Revenue by Manufacturers (2015 and 2016)
Table United States Doxorubicin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Doxorubicin Revenue Share by Manufacturers
Table 2016 United States Doxorubicin Revenue Share by Manufacturers
Table United States Market Doxorubicin Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Doxorubicin Average Price of Key Manufacturers in 2015
Figure Doxorubicin Market Share of Top 3 Manufacturers
Figure Doxorubicin Market Share of Top 5 Manufacturers
Table United States Doxorubicin Sales by Type (2011-2016)
Table United States Doxorubicin Sales Share by Type (2011-2016)
Figure United States Doxorubicin Sales Market Share by Type in 2015
Table United States Doxorubicin Revenue and Market Share by Type (2011-2016)
Table United States Doxorubicin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Doxorubicin by Type (2011-2016)
Table United States Doxorubicin Price by Type (2011-2016)
Figure United States Doxorubicin Sales Growth Rate by Type (2011-2016)
Table United States Doxorubicin Sales by Application (2011-2016)
Table United States Doxorubicin Sales Market Share by Application (2011-2016)
Figure United States Doxorubicin Sales Market Share by Application in 2015
Table United States Doxorubicin Sales Growth Rate by Application (2011-2016)
Figure United States Doxorubicin Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Doxorubicin Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Doxorubicin Sales Market Share (2011-2016)
Table Sun Pharmaceutical Industries Basic Information List
Table Sun Pharmaceutical Industries Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sun Pharmaceutical Industries Doxorubicin Sales Market Share (2011-2016)
Table Meiji Seika Pharma Basic Information List
Table Meiji Seika Pharma Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Meiji Seika Pharma Doxorubicin Sales Market Share (2011-2016)
Table MicroBiopharm Japan Basic Information List
Table MicroBiopharm Japan Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
Table MicroBiopharm Japan Doxorubicin Sales Market Share (2011-2016)
Table Teva Basic Information List
Table Teva Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Doxorubicin Sales Market Share (2011-2016)
Table Boryung Basic Information List
Table Boryung Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boryung Doxorubicin Sales Market Share (2011-2016)
Table Synbias Pharma Basic Information List
Table Synbias Pharma Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Synbias Pharma Doxorubicin Sales Market Share (2011-2016)
Table Sterling Basic Information List
Table Sterling Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sterling Doxorubicin Sales Market Share (2011-2016)
Table LINGNAN Pharmaceutical Basic Information List
Table LINGNAN Pharmaceutical Doxorubicin Sales, Revenue, Price and Gross Margin (2011-2016)
Table LINGNAN Pharmaceutical Doxorubicin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Doxorubicin
Figure Manufacturing Process Analysis of Doxorubicin
Figure Doxorubicin Industrial Chain Analysis
Table Raw Materials Sources of Doxorubicin Major Manufacturers in 2015
Table Major Buyers of Doxorubicin
Table Distributors/Traders List
Figure United States Doxorubicin Production and Growth Rate Forecast (2016-2021)
Figure United States Doxorubicin Revenue and Growth Rate Forecast (2016-2021)
Table United States Doxorubicin Production Forecast by Type (2016-2021)
Table United States Doxorubicin Consumption Forecast by Application (2016-2021)